Disclosure of Interests definition

Disclosure of Interests. ▇▇▇▇ ▇▇▇▇▇▇▇ Floeistrup ▇▇▇▇▇▇▇: None declared, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇: None declared, ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇: None declared, ▇▇▇▇ ▇▇▇▇▇: None declared, ▇▇▇▇▇ ▇▇▇▇▇▇: None declared, ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇: None declared, ▇▇▇▇▇ Møllenbach ▇▇▇▇▇▇: None declared, Mikkel Ǿstergaard Grant/research support from: ▇▇▇▇▇▇, ▇▇▇▇▇▇▇, Cento- cor, Merck, Novartis, Consultant for: Abbvie, BMS, Boehringer-Ingelheim, Celgene, ▇▇▇ ▇▇▇▇▇, Hospira, ▇▇▇▇▇▇▇, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, and UCB, Speakers bureau: Abbvie, BMS, ▇▇▇▇- ▇▇▇▇▇▇-Ingelheim, Celgene, ▇▇▇ ▇▇▇▇▇, Hospira, ▇▇▇▇▇▇▇, Merck, Novartis, Novo, Orion, Pfizer, Regeneron, Roche, and UCB DOI: 10.1136/annrheumdis-2019-eular.1951 1Croydon Health Services NHS Trust, Rheumatology, Croydon, United Kingdom; 2St George’s University Hospital NHS Trust, Rheumatology, Tooting, United Kingdom; 3Epsom and St Helier’s NHS Trust, Rheumatology, Carshalton, United Kingdom; 4King’s College Hospital NHS Foundation Trust, Rheumatology, Orpington, United Kingdom Background: To ensure a timely diagnosis of RA, diagnostic US is increasingly being utilized to detect subclinical pathology in order to implement treatment plans rapidly. There are several ‘optimal’ synovitis scoring protocols in the literature but a consensus regarding a definitive system still eludes us. There are few studies that have focussed specifi- cally on wrist US pathology in early RA. Hence, we assessed what the common wrist US pathologies are in patients diagnosed with early RA. Objectives: To identify the patterns of wrist US abnormalities seen in patients diagnosed with early RA from our EIA service in a large urban London hospital. Methods: Retrospective service review of patients seen in the EIA US diagnostic service at Croydon Health Services in South London. Patients diagnosed with RA (EULAR/ACR 2010 criteria) with wrist US synovitis/ tenosynovitis (EULAR-OMERACT definitions) between Jan2017-Dec2018 were included. The US protocol in the EIA diagnostic service includes lateral and dorsal (long axis & short axis views) of the ulnarcarpal(UCJ) & radiocarpal(RCJ) joints with views covering the radioulnar joints & ulnar-styloids and views of the extensor & flexor tendons. Images and reports were reviewed and correlations with rheumatoid factor(RhF), anti- CCP antibodies(CCP), CRP & ESR were also assessed.
View Source
Disclosure of Interests. You fully understand that the Bank plays a variety of roles in connection with the Structured Investment including acting as Calculation Agent and hedging its obligations under this Structured Investment. The Bank and/or any of its related companies, in the ordinary course of their business, may also effect transactions for their own account or for the account of their customers. In conducting such business neither the Bank nor any of its related companies is obliged to take into account your circumstances or act in a manner which is favourable to you. You fully understand that such activity may, or may not affect the value of the Structured Investment and you are aware that a conflict may arise
View Source
Disclosure of Interests. None Declared. DOI: 10.1136/annrheumdis-2023-eular.5508 FUNCTION AND PAIN IN KNEE JOINTS IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER TOTAL KNEE ARTHROPLASTY Keywords: Osteoarthritis, Rheumatoid arthritis
View Source

Examples of Disclosure of Interests in a sentence

  • CERTAIN OBLIGATIONS OF OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES 13 SECTION 3.1. Filing Proofs, Certificates and Other Information 13 SECTION 3.2. Liability of Owner for Taxes 13 SECTION 3.3. Warranties on Deposit of Shares 14 SECTION 3.4. Disclosure of Interests 14 ARTICLE 4.

  • CERTAIN OBLIGATIONS OF OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES 12 SECTION 3.1. Filing Proofs, Certificates and Other Information 12 SECTION 3.2. Liability of Owner for Taxes 13 SECTION 3.3. Warranties on Deposit of Shares 13 SECTION 3.4. Disclosure of Interests 13 ARTICLE 4.

  • The Depositary will only exercise voting rights with respect to the Shares that it holds under the Deposit Agreement if the Company has registered such Shares with voting rights in its share register pursuant to the Company’s Articles of Association and the Nominee Agreement as provided in paragraph 6 (Disclosure of Interests) herein Section 6 of the form of ADR attached as Exhibit A hereto.

  • The Depositary further agrees that it shall cooperate with the Company in enforcing the provisions of the Hong Kong Securities (Disclosure of Interests) Ordinance and any other legislation or regulations of Hong Kong from time to time relating to disclosure of interests, including sanctions that the Company may invoke in the event a Holder fails to provide certain requested information concerning interests in Receipts or Deposited Securities.

  • Consultant agrees to comply with City of Corpus Christi Ordinance No. 17112 and complete the Disclosure of Interests form, attached as Exhibit D.

  • CERTAIN OBLIGATIONS OF OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES 12 SECTION 3.1. Filing Proofs, Certificates and Other Information 12 SECTION 3.2. Liability of Owner for Taxes 12 SECTION 3.3. Warranties on Deposit of Shares 13 SECTION 3.4. Disclosure of Interests 13 ARTICLE 4.

  • CERTAIN OBLIGATIONS OF OWNERS AND HOLDERS OF AMERICAN DEPOSITARY SHARES 12 SECTION 3.1. Filing Proofs, Certificates and Other Information 12 SECTION 3.2. Liability of Owner for Taxes 13 SECTION 3.3. Warranties on Deposit of Shares 13 SECTION 3.4. Disclosure of Interests 14 ARTICLE 4.

  • Owners will be subject to the provisions of the Hong Kong Securities (Disclosure of Interests) Ordinance (the "Ordinance") and any other legislation or regulations of Hong Kong from time to time in effect regarding the disclosure of interests in Shares.

  • Disclosure of Interests: You fully understand that the Bank plays a variety of roles in connection with the Structured Investment including acting as Calculation Agent and hedging its obligations under this Structured Investment.

  • Owners and Beneficial Owners will be subject to the provisions of the Hong Kong Securities (Disclosure of Interests) Ordinance (the “Ordinance”) and any other legislation or regulations of Hong Kong from time to time in effect regarding the disclosure of interests in Shares.


More Definitions of Disclosure of Interests

Disclosure of Interests. None Declared. DOI: 10.1136/annrheumdis-2023-eular.2190 QUANTIFICATION OF TENOSYNOVITIS IN RA FROM WRIST MRIS, BASED ON DEEP LEARNING Keywords: Artificial intelligence, Rheumatoid arthritis, Imaging
View Source
Disclosure of Interests. ▇▇▇▇▇▇▇▇ ▇▇▇▇: None declared, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇: None declared, ▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇: None declared, ▇▇▇▇▇ ▇▇▇▇▇▇: None declared, ▇▇▇▇ ▇▇▇▇▇▇▇ Speakers bureau: Novartis, Pfizer, UCB, ▇▇▇▇▇▇▇ and GE AB0510 ▇. ▇▇▇▇▇▇▇,2, ▇. ▇. ▇▇▇▇▇▇▇,2, M. Y. MD Yusof1,2, Z. Wigston1,2, S. U. Hassan1,2, ▇. ▇▇▇▇▇▇▇,2, ▇. ▇▇▇▇▇,2, ▇. ▇▇▇▇▇▇▇▇,2, ▇. ▇▇▇▇▇▇,2. 1University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom; 2Leeds Teaching Hospitals NHS Trust, NIHR Leeds Biomedical Research Centre, Leeds, United Kingdom
View Source
Disclosure of Interests. None Declared. DOI: 10.1136/annrheumdis-2023-eular.4419 CAN RHEUMATOID ARTHRITIS IMPACT OF DISEASE (RAID) SCORE BE USED AS A PATIENT REPORTED OUTCOME BASED TARGET IN A TREAT-TO-TARGET APPROACH: A PROSPECTIVE STUDY FROM INDIA Keywords: Patient reported outcomes, Rheumatoid arthritis, Treat to target Background: Rheumatoid arthritis impact of disease (RAID) is a well validated patient reported outcome (PRO) in patients with Rheumatoid Arthritis (RA) [1]. RAID score involves the active participation of patients and can be easily cal- culated at the comfort of home with minimal training and assistance or while the patient is waiting to see the doctor in the outpatient department. It is helpful in giving an idea of the overall well-being of the patient and takes into account sleep and depression which are the unmet needs in RA treatment. However, the effectiveness of RAID as a patient reported outcome and the optimal RAID score which can be used as a target for treat-to-target approach has not been studied in the Indian population. Objectives: To determine if the RAID score can be used as a PRO target along with a clinician reported disease activity score for managing patients with RA under a treat-to-target approach. To establish an acceptable cut-off for the RAID score which can be used as a target in patients with RA and validate it against disease activity indices.
View Source
Disclosure of Interests. None Declared. DOI: 10.1136/annrheumdis-2023-eular.4473 ASSESSMENT OF STIGMATIZATION IN RHEUMATOID ARTHRITIS USING THE STIGMA SCALE FOR CHRONIC ILLNESSES-SHORT FORM (SSCI-8) Keywords: Rheumatoid arthritis, Cognitive function, Mental health Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease that occurs among productive patients. It often causes functional disability that can be permanent, with both physical and mental impact. Objectives: We aimed to assess the degree of stigmatization and associated factors in patients with RA.
View Source
Disclosure of Interests. None Declared. DOI: 10.1136/annrheumdis-2023-eular.4372 VALIDATION OF REVISED 2022 ACR/EULAR REMISSION CRITERIA FOR RHEUMATOID ARTHRITIS IN ASIAN INDIAN RHEUMATOID ARTHRITIS PATIENTS Keywords: Outcome measures, Rheumatoid arthritis Background: Remission has become a key target in the management of rheu- matoid arthritis (RA) patients[1]. In 2022, American College of Rheumatology (ACR) and European League Against Rheumatism (EULAR) has revised the Boolean based remission criteria in RA by increasing the patient global assess- ment of disease activity (PtGA) threshold to ≤2cm (range 0–10 cm). This has not been validated in an Asian Indian cohort of RA patients[2,3]. Results: This study included 125 patients, majority being females (105 (84%)), with mean (±SD) age of 42.8 (±10.8) years and mean (±SD) disease duration of 2 (±1.5) years. At 24-weeks, using the index based (SDAI and CDAI) ▇▇▇▇▇- ria, remission was achieved in 24.8% and 24% of patients respectively. Among the various Boolean criteria, remission occurred in only 21.6% using the original Boolean1.0. This increased with Boolean2.0 to 23.2%, and further increased with Boolean2.5 and Boolean X [Figure 1]. The highest agreement between SDAI or CDAI-defined remission was found to occur with Boolean2.0-defined remission rather than Boolean1.0 (or 1.5, 2.5 or X) defined remission [Table 1]. Also, there was strong agreement (0.89 (95% CI 0.79-0.99)) between SDAI and CDAI-de- fined remission criteria. Conclusion: We validated the performance of revised 2022 ACR/▇▇▇▇▇ ▇▇▇▇▇- sion criteria for RA in Asian Indian RA patients and found the higher agreement of Boolean2.0 (rather than Boolean1.0) with index-based remission cutoffs.
View Source

Related to Disclosure of Interests

  • Restricting Information has the meaning specified in Section 10.09(a).

  • Disclosures means the disclosures set out in ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ .

  • Disclosure shall have the meaning given to such term under the HIPAA regulations in 45 CFR § 160.103.

  • Disclosed means fairly disclosed (with sufficient details to identify the nature and scope of the matter disclosed) in or under the Disclosure Letter;

  • Information Disclosure Requirements means the requirements to disclose information under: